STOPPING bisphosphonates (alendronate, etc) after 3 to 5 years in patients at low fracture risk

   Experts continue to suggest STOPPING bisphosphonates (alendronate, etc) after 3 to 5 years in patients at low fracture risk.

   Bisphosphonates persist in the bones for years, so 3 to 5 years of therapy is enough for many patients.

   Advise patients taking bisphosphonates for many years to talk to their prescriber about possibly stopping the drug.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote